The neuropsychiatric inventory: Assessing psychopathology in dementia patients

被引:1596
作者
Cummings, JL
机构
[1] UNIV CALIF LOS ANGELES, SCH MED, REED NEUROL RES CTR, DEPT PSYCHIAT & BEHAV SCI, LOS ANGELES, CA 90095 USA
[2] W LOS ANGELES VET AFFAIRS MED CTR, PSYCHIAT SERV, NEUROBEHAV & NEUROPSYCHIAT PROGRAM, LOS ANGELES, CA 90073 USA
关键词
D O I
10.1212/WNL.48.5_Suppl_6.10S
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
The Neuropsychiatric Inventory (NPI) was developed to assess psychopathology in dementia patients. It evaluates 12 neuropsychiatric disturbances common in dementia: delusions, hallucinations, agitation, dysphoria, anxiety, apathy, irritability, euphoria, disinhibition, aberrant motor behavior, night-time behavior disturbances, and appetite and eating abnormalities. The severity and frequency of each neuropsychiatric symptom are rated on the basis of scripted questions administered to the patient's caregiver. The NPI also assesses the amount of caregiver distress engendered by each of the neuropsychiatric disorders. A total NPI score and a total caregiver distress score are calculated, in addition to the scores for the individual symptom domains. Content validity, concurrent validity, inter-rater reliability, and test-retest reliability of the NPI are established. Different neurologic disorders have characteristic neuropsychiatric manifestations and distinctive NPI profiles. The NPI is sensitive to treatment effects and has demonstrated the amelioration of behavioral symptoms in Alzheimer's disease by cholinergic agents. The NPI is a useful instrument for characterizing the psychopathology of dementia syndromes, investigating the neurobiology of brain disorders with neuropsychiatric manifestations, distinguishing among different dementia syndromes, and assessing the efficacy of treatment.
引用
收藏
页码:S10 / S16
页数:7
相关论文
共 62 条
  • [51] RUBIN EH, 1989, AM J PSYCHIAT, V146, P1017
  • [52] Ryden M B, 1988, Alzheimer Dis Assoc Disord, V2, P342, DOI 10.1097/00002093-198802040-00003
  • [53] A SPECT STUDY OF DELUSIONS IN ALZHEIMERS-DISEASE
    STARKSTEIN, SE
    VAZQUEZ, S
    PETRACCA, G
    SABE, L
    MIGLIORELLI, R
    TESON, A
    LEIGUARDA, R
    [J]. NEUROLOGY, 1994, 44 (11) : 2055 - 2059
  • [54] STEELE C, 1990, AM J PSYCHIAT, V147, P1049
  • [55] UTILITY OF EXTRAPYRAMIDAL SIGNS AND PSYCHOSIS AS PREDICTORS OF COGNITIVE AND FUNCTIONAL DECLINE, NURSING-HOME ADMISSION, AND DEATH IN ALZHEIMERS-DISEASE - PROSPECTIVE ANALYSES FROM THE PREDICTORS STUDY
    STERN, Y
    ALBERT, M
    BRANDT, J
    JACOBS, DM
    TANG, MX
    MARDER, K
    BELL, K
    SANO, M
    DEVANAND, DP
    BYLSMA, F
    LAFLECHE, G
    [J]. NEUROLOGY, 1994, 44 (12) : 2300 - 2307
  • [56] SULTZER DL, 1995, J NEUROPSYCH CLIN N, V7, P476
  • [57] Physical aggression is associated with preservation of substantia nigra pars compacta in Alzheimer disease
    Victoroff, J
    Zarow, C
    Mack, WJ
    Hsu, E
    Chui, HC
    [J]. ARCHIVES OF NEUROLOGY, 1996, 53 (05) : 428 - 434
  • [58] WRAGG RE, 1989, AM J PSYCHIAT, V146, P577
  • [59] ZUBENKO GS, 1992, NEUROPSYCHOPHARMACOL, V6, P77
  • [60] NEUROPATHOLOGIC AND NEUROCHEMICAL CORRELATES OF PSYCHOSIS IN PRIMARY DEMENTIA
    ZUBENKO, GS
    MOOSSY, J
    MARTINEZ, AJ
    RAO, G
    CLAASSEN, D
    ROSEN, J
    KOPP, U
    [J]. ARCHIVES OF NEUROLOGY, 1991, 48 (06) : 619 - 624